ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

Varmus, Duke Ask IOM To Investigate Potti’s Scientific Work, Clinical Trials

July 30, 2010

FCRC Preproposal Conference Draws 36 Institutions

August 14, 1981

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

NCI Advisory Group, Other Cancer Meetings

October 26, 1984

For A Better View Of Molecular Targets, NCI Project To Draw Pictures Of Cancers.

June 15, 2001

In Brief: Grants To Get Biggest Share Of NCI’s Extra $74 Million; A PR Failure In Pittsburgh

March 19, 1976